Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections are increasingly available ...
A growing number of states are rolling back financial help for HIV medications, according to a recent analysis.
Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.
Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.
Sexually transmitted diseases or STDs (formerly called venereal diseases) are among the world's most common infectious diseases. These bacterial or viral diseases are spread through sexual contact.
From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope ...
Health and Me on MSN
Years after PrEP rollout, the HIV prevention drug still remains a privilege in India
India introduced PrEP guidelines in 2022, but access remains limited due to lack of public rollout, low awareness, and high costs. Meanwhile, HIV prevalence has declined overall but remains ...
The AIDS Healthcare Foundation (AHF) says women and girls account for more than 60 percent of new HIV infections in sub-Saharan Africa.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results